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Abstract This Perspective, arising from a workshop held
in July 2008 in Buffalo NY, provides an overview of the
role NMR has played in the United States Protein Structure
Initiative (PSI), and a vision of how NMR will contribute
to the forthcoming PSI-Biology program. NMR has con-
tributed in key ways to structure production by the PSI, and
new methods have been developed which are impacting the
broader protein NMR community.
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The mission of structural coverage of most protein domain
families, pioneered in PSI phases 1 and 2, is well on its way
to completion [6]. NMR has played an integral role in this
endeavor [35, 43]. The goal of structural coverage at a
sequence identity level of *30% for most protein domains
in nature will represent a monumental achievement for
humankind, contributing in many ways toward our under-
standing of the relationships between protein sequence,
structure, and function. As we ponder the future contribu-
tions of structural genomics (SG) for biomedical research,
we envision many future opportunities beyond structure
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DOI 10.1007/s10969-009-9064-0production that have been created by these high throughput
structural biology platforms.
In the coming years, target selection strategies likely
will go beyond the current sparse sampling of representa-
tive members of protein families to strategies aimed at
providing extensive structural coverage of functional bio-
logical systems at high resolution. These systems could
include (i) signaling networks and metabolic pathways, (ii)
proteomes of medically important species, particularly
humans, (iii) human disease-related proteins including
infectious diseases, (iv) the human and environmental
microbiomes (‘metagenomics’), and (v) comparative
analysis of structure, dynamics, and biochemical function
across protein families. The application of SG platforms to
one or more of these biological systems would leverage
NIH’s investment in SG pipelines to further our under-
standing of fundamental mechanisms of protein function,
molecular evolution, biological processes, and human dis-
ease at a reduced cost. Alternatively, SG centers could be
redeﬁned to focus on increasing the range and types of
structures that presently cannot be routinely determined or
modeled; for example, membrane proteins, higher order
protein complexes, and eukaryotic proteins with extensive
natively disordered regions and/or posttranslational
modiﬁcations.
In considering future efforts, we note that the puriﬁed
proteins themselves are among the most valuable products
of SG efforts. The largest expense in SG is the preparation
of pure, soluble protein. Much more could be done with
these proteins, particularly the large fraction that does not
readily yield structures. Given that all proteins carry out
their biochemical function through their interactions with
other molecules, we propose that the full realization of the
potential of SG platforms must integrate studies of func-
tionally relevant interacting molecules for each protein
target. Therefore, we envision that a key element of future
SG projects or platforms would include a systematic
attempt to integrate experimental protein binding, and/or
biochemical information with structural data. Examples of
such strategies, which would include HTP biochemical
characterization of proteins, are (i) screening of ligand
binding coupled with 3D structure analysis of functional
protein-ligand complexes (see, for example, [23, 37], (ii)
screening or characterization of enzymatic activity coupled
with 3D structures of relevant protein substrate/cofactor/
inhibitor complexes (see, for example, [28], and (iii)
identiﬁcation of protein-protein interaction partners cou-
pled with 3D structures of relevant multiprotein complexes.
A particularly powerful application of such integrated SG/
functional studies would be the systematic and compre-
hensive characterization of the structural basis of ligand (or
substrate) binding speciﬁcity of proteins with related, but
distinct, binding proﬁles, so as to understand the structural
basis of their speciﬁcity. Here we deﬁne ‘‘ligand’’ as any
small molecule or macromolecule that interacts function-
ally with a protein. By adopting this approach, SG would
have stronger synergy with functional genomics activities,
and better integration with systems biology. These studies
would also identify complexes that stabilize protein struc-
tures, and enable structures to be determined for otherwise
refractory proteins.
NMR spectroscopy has a unique and valuable role in
SG
During the course of PSI phases 1 and 2, we have shown
that NMR is a highly complementary approach to X-ray
crystallography for protein structure determination [32,
44]. Many proteins that provide good NMR spectra have
not been successfully crystallized. In particular, in contrast
to X-ray crystallography, NMR is about equally successful
for prokaryotic and eukaryotic proteins. Therefore, com-
prehensive structural coverage of any protein system
involving small to medium sized proteins would beneﬁt
from an NMR component.
NMR data provide the basis for extending the static
structural view of proteins, through the rapid identiﬁcation
of natively unfolded proteins and residue-speciﬁc charac-
terization of disordered protein segments, including
functionally important ﬂexible surface loops. NMR is also
an essential tool for characterizing alternative conforma-
tions and allosteric states. In some cases, the minor
conformational states that can only be characterized by
NMR studies are critically important for biological func-
tion. NMR can also be used to measure the rates of
transitions between these conformational states. As such,
future SG efforts seeking to understand the evolution of
structural, functional, and dynamic diversity across a pro-
tein family will require NMR studies to provide dynamic
information.
NMR is also a powerful method for screening of func-
tional protein-ligand, protein-protein, and protein-nucleic
acid interactions. While other biophysical techniques are
also capable of identifying such interactions, NMR is
uniquely able to identify even transient, but functionally
important, interactions. The protein samples, and most of
the instrumentation and techniques required for rapid NMR
screening studies, are the same as those already used in PSI
NMR structure determination pipelines, allowing easy
integration of functional screening techniques. NMR
methods are also valuable for validating initial ‘hits’
identiﬁed in HTP screening. It is important to recognize
that the use of NMR as a HTP screening tool is not limited
by protein size, since one may monitor either the protein or
the ligand to detect the interaction.
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123Finally, NMR data are used to generate new functional
hypotheses, and to conﬁrm functional annotations, inter-
actions, or biochemical reaction rates revealed in other
‘‘omics’’ projects (e.g., functional genomics, transcripto-
mics, or metabonomics). Hence, we envision that NMR
will play a key role to connect SG with these ‘omics’
approaches, thereby better integrating SG into systems
biology.
Accomplishments of NMR SG groups during PSI
One Large Scale Center, The Northeast Structural
Genomics Consortium (NESG), and one Specialized Cen-
ter, the Center for Eukaryotic Structural Genomics
(CESG), have made major commitments to protein NMR
sample and structure production. The two centers have
deposited into the PDB some 300 protein NMR structures
([90% of the PSI NMR structures) over the ﬁrst 8 years of
the PSI program. Thus, with *12% of PSI resources
dedicated to NMR pipelines, *10% of PSI structures have
been determined by NMR. Given similar levels of support
and priority in these two centers, NMR makes contribu-
tions to structure production that are comparable to X-ray
crystallography (Fig. 1, left panel). The Joint Center for
Structural Genomics (JCSG), Center for Structure of
Membrane Proteins (CSMP), and New York Center on
Membrane Protein Structure (NYCOMPS) have also used
NMR effectively, though with a smaller percentage effort.
Many of these structures would not have been solved
without the participation of NMR. Indeed, *15% of small
proteins provided by other Large Scale Centers to NESG
NMR groups, because they could not be crystallized suc-
cessfully, subsequently provided 3D structures by NMR.
Many other potential opportunities to solve PSI target
structures may have been missed by the other PSI centers,
where NMR-tractable proteins have been produced, but not
pursued by NMR analysis.
Comparison of PSI and non-SG protein NMR structures
deposited in the PDB during the same time period reveals
that (i) the average molecular weight (MW) of PSI NMR
structures, *13 kDa, is similar to that of non-SG structures
(Fig. 1, right panel), (ii) the fraction of homo-oligomeric
protein structures (*15%) is also about the same, but (iii)
the quality of PSI NMR structures is signiﬁcantly better,
when considering PROCHECK dihedral angle distribution
and MOLPROBITY atomic clash scores (Fig. 2). As a
consequence, PSI NMR structures are generally of sufﬁ-
ciently high accuracy to be used in crystallographic
molecular replacement studies [30], and as useful as
medium-resolution (1.8–2.5 A ˚) X-ray crystal structures for
high-quality homology modeling (e.g., [22, 24]). The PSI
NMR structure pipelines have also demonstrated that they
can address challenging protein targets, including proteins
with MW 20–35 kDa (Fig 1, right panel), dimeric and
tetrameric proteins, and membrane proteins.
NESG, CESG, and JCSG have also developed new
methodology for lowering the costs per NMR structure,
including (i) protocols for HTP preparation of
13C/
15N- and
13C/
15N/
2H- enriched samples using novel eukaryotic
wheat-germ based cell-free expression systems [39, 40]
and bacterial single protein production (SPP) systems [29,
33, 34], (ii) HTP NMR screening platforms using micro-
probe robotics for buffer and construct optimization [1],
(iii) GFT NMR [2, 3, 19, 20, 36], and related HIFI [8] and
APSY [13–15] NMR experiments for reducing NMR
measurement times by more than an order of magnitude,
(iv) software for semi-automated data analysis and struc-
ture calculations [4, 9–18, 21, 25, 26, 41, 46], (v) software
and protocols for structure validation and reﬁnement based
on residual dipolar couplings (RDCs) and chemical shifts
[31, 38, 42], and (vi) software and servers for compre-
hensive structure quality assessment [5, 17] and reﬁnement
[30]. These methods have reduced the average time
required per structure to 2–3 weeks for small to medium
sized proteins; in favorable cases, NMR structures are
Fig. 1 (left panel) In the two PSI centers with major commitments to
NMR sample and structure production some 37% of structures were
determined by NMR (42% and 22% in NESG and CESG, respec-
tively). (right panel) MW distributions for protein NMR structures
([50 residues) determined by PSI groups and non SG groups in the
same time period are similar. Inset—histogram plot of MW distri-
bution of PSI NMR structures. Statistics were compiled in October
2008
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123determined in only a few days. Although not in the original
charge to the PSI NMR groups, recent efforts in technology
development have focused on addressing larger proteins,
oligomeric structures, and protein-protein complexes. For
example, the NYCOMPS and CSMP have made signiﬁcant
advances in developing new methods for sample prepara-
tion and NMR analysis of membrane protein structures
[45, 27].
A promising future for NMR contributions to SG and
the larger biomedical community
NMR’s role in structural biology is still rapidly evolving.
Unlike x-ray crystallography, which has matured to a state
in which almost all aspects can be highly automated, NMR
is still approaching this goal. We are very optimistic that
over the next decade NMR will continue to make gains
analogous to those seen for crystallography over the past
few decades. For example, recent advances demonstrate
that sparse constraints, such as chemical shift, residual
dipolar coupling data, and/or small numbers of long-range
distance constraints, can be combined with conformational
energy calculations to provide good quality protein struc-
tures. These emerging technologies will expand the range
of proteins that can be addressed at high resolution by
NMR, as well as the speed with which this can be done.
The new avenues of biological research opened by SG
platforms will be tremendously enhanced by these NMR
technologies. Clearly, NMR approaches offer tremendous
opportunities for SG projects, and will be required in order
to extract the greatest knowledge and understanding of
whichever biological systems are targeted in the next phase
of SG research.
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